I would only add that like Ms. Cobden's industry, we're in the supply chain as well. Biotechnology is allowing a lot of industries to transform. Any sort of trade agreement that expands markets for other industries in which we're sort of central is good news for biotechnology ultimately.
When you look at mining, for instance, or at oil and gas, oil and gas is using a company out of Quebec City that has an enzyme that basically gobbles up their CO2 emissions. That company is going to do well as long as the oil and gas industry is going to do well. That's probably not the best example, because we know that oil and gas is going to continue to do well for a while, but there certainly are other industries where biotechnology is central to the transformation of those industries. As those industries compete more in the bioeconomy, biotechnology will be central to that and will benefit accordingly.